News
Connecting the dots in rare disease drug discovery
Graph intelligence is redefining what is possible in drug discovery by making sense of what already exists.
September 14, 2026What is missing in the fight against AI-enabled fraud
Connected-data approaches are becoming essential because AI-enabled fraud often leaves patterns across networks, even when individual events appear legitimate.
September 5, 2026Data Lineage Matters in the Age of AI, and Graphs Make It Possible
As AI grows in India’s digital economy, trust will rely not only on intelligence but also on understanding the origins of data and its connections.
August 31, 2026Existing Medicines, New Possibilities – How Graph Intelligence is Accelerating Rare Disease Discovery
Healthcare is generating more biomedical data than ever before. Yet, turning that data into insights to inform new treatments remains a challenge.
August 11, 2026Fragmented data is becoming a systemic risk to fragile global supply chains
Hidden dependencies and bad data in critical systems are leaving civilization exposed to cascading disruption, warns Chris Upkes of Neo4j.
August 10, 2026Why India’s AI moment depends on context, not compute
The Indian economy is experiencing rapid advances in the field of artificial intelligence. Today, banks are using AI solutions for decision-making on credit to customers; telecommunications companies are using automation for managing networks; and government organizations are investigating how they…
July 8, 2026Letter: Three tests for platforms running critical services
The UK is right to question the platforms behind its critical services. But the debate should not be reduced to whether one provider is trusted. What matters more is whether public institutions retain control as advanced data and AI platforms…
June 28, 2026Old discoveries, new cures – supercharging rare disease treatment with graph intelligence
Despite over [300 million people](<https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(24)00056-1/fulltext>) globally living with a rare disease, patients often wait nearly five years for a confirmed diagnosis. In the UK alone, only 5% of rare diseases have an approved treatment. Even with years of investment and…
June 25, 2026Five best practices to handle current and future AI privacy and governance regulations
AI regulations are moving forward in many countries and states, but not with a sense of consistency that gives organizations a clear path to stay compliant. Some areas are moving quickly, others more deliberately. Meanwhile, models, tooling, and agent frameworks…
June 23, 2026